Clayton Dubilier and Rice Revenue and Competitors
Estimated Revenue & Valuation
- Clayton Dubilier and Rice's estimated annual revenue is currently $80.8M per year.
- Clayton Dubilier and Rice received $6250.0M in venture funding in February 2014.
- Clayton Dubilier and Rice's estimated revenue per employee is $266,700
Employee Data
- Clayton Dubilier and Rice has 303 Employees.
- Clayton Dubilier and Rice grew their employee count by 20% last year.
Clayton Dubilier and Rice's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Head Business Technology Services (Business Applications & Digital Technology) | Reveal Email/Phone |
3 | VP, Tax Strategy | Reveal Email/Phone |
4 | Head Tax | Reveal Email/Phone |
5 | AVP | Reveal Email/Phone |
6 | Controller | Reveal Email/Phone |
7 | Vice Chairman | Reveal Email/Phone |
8 | Head Human Resources | Reveal Email/Phone |
9 | Vice Chairman | Reveal Email/Phone |
10 | VP Administration | Reveal Email/Phone |
Clayton Dubilier and Rice Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $80.8M | 303 | 20% | N/A | N/A |
What Is Clayton Dubilier and Rice?
Founded in 1978, Clayton, Dubilier & Rice is an investment firm with an investment strategy predicated on building stronger, more profitable businesses. We work collaboratively with corporate and family business sellers on transactions to maximize value. We believe many corporations, CEOs and entrepreneurs select CD&R as their partner because of our reputation for trustworthiness and operational leadership. We practice investing as a craft, relying on a dedicated and cohesive team with a shared sense of purpose and values. Our investment approach blends skilled investment judgment with extensive experience driving growth and operating excellence.
keywords:Biotechnology,Cleantech,Finance,Wind Power
N/A
Total Funding
303
Number of Employees
$80.8M
Revenue (est)
20%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Clayton Dubilier and Rice News
Humana Inc. (NYSE: HUM) signed a definitive agreement with private investment firm Clayton, Dubilier & Rice (CD&R) to divest a majority...
(NYSE: HUM) today announced that it has signed a definitive agreement with private investment firm Clayton, Dubilier & Rice (CD&R) to divest a...
Humana Inc. is in advanced talks to sell an arm of Kindred at Home to private equity firm Clayton Dubilier & Rice in a deal that would value...
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $54.9M | 303 | N/A | N/A |
#2 | $53.9M | 303 | 15% | $39M |
#3 | $45.5M | 303 | 9% | N/A |
#4 | $102.3M | 303 | N/A | N/A |
#5 | $102.3M | 303 | 4% | N/A |
Clayton Dubilier and Rice Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2014-02-28 | $6250.0M | IX | Donald Gogel | Article |